KRYS vs LCID · P/E 46, rev $235.6M vs rev $687.8M
Krystal Biotech Inc (KRYS) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. LCID currently screens at market cap $2.04B.
Not investment advice. Open the KRYS and LCID stock pages for the full models.
Not investment advice.